Product NDC: | 0409-4350 |
Proprietary Name: | Diltiazem Hydrochloride |
Non Proprietary Name: | DILTIAZEM HYDROCHLORIDE |
Active Ingredient(s): | 100 mg/1 & nbsp; DILTIAZEM HYDROCHLORIDE |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | POWDER, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0409-4350 |
Labeler Name: | Hospira, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075853 |
Marketing Category: | ANDA |
Start Marketing Date: | 20111020 |
Package NDC: | 0409-4350-03 |
Package Description: | 10 VIAL, PATENT DELIVERY SYSTEM in 1 TRAY (0409-4350-03) > 1 POWDER, FOR SOLUTION in 1 VIAL, PATENT DELIVERY SYSTEM |
NDC Code | 0409-4350-03 |
Proprietary Name | Diltiazem Hydrochloride |
Package Description | 10 VIAL, PATENT DELIVERY SYSTEM in 1 TRAY (0409-4350-03) > 1 POWDER, FOR SOLUTION in 1 VIAL, PATENT DELIVERY SYSTEM |
Product NDC | 0409-4350 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | DILTIAZEM HYDROCHLORIDE |
Dosage Form Name | POWDER, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20111020 |
Marketing Category Name | ANDA |
Labeler Name | Hospira, Inc. |
Substance Name | DILTIAZEM HYDROCHLORIDE |
Strength Number | 100 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC] |